SharonAI Holdings, Inc. Class A Common Stock
NASDAQ:SHAZInformation Technology Services
+$5.13 today
- Market cap
- $784.32M
- Beta
- 5.93
- P/E (TTM)
- -21.7
- EPS (TTM)
- -$4.16
Volume 3.48M
Average 0.56M
SHAZ Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
SharonAI Holdings, Inc. Class A Common StockNASDAQ: SHAZ
Net Debt · Q2 FY2026 · quarter ended Jun 2026
Net debt turns negative
Q2 FY2026 net debt was -$849.99M, compared with $754.95K a year earlier.
Context
- Net debt amounted to 36.6% of total assets at the end of Q2 FY2026, up 34.1 pp from a year earlier.
What to watch
Whether net debt keeps falling in the next quarterly balance sheet after a -112689.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- 65.19M USD
- Year-over-year change
- +1977.2%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 65.19M | +1977.2% |
| FY2024 | 2024-12-31 | (3.47M) | — |
Net Debt vs competitors
How SHAZ compares with its peers on the latest reported figures
- SHAZ's Jun 2026 net debt of -$849.99M is the lowest of the 7 companies compared; the peer median is $1.13B.
- Its year-over-year change of -112689.1% is the lowest of 7, against a peer median of +322.6%.
- Net debt amounts to 36.6% of total assets for SHAZ, versus a peer median of 22.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $60.69B | +258.8% | — | 66.3% | |
| Aug 2026 | $3.53B | +464.2% | +282.2% | 30.2% | |
| Jun 2026 | $1.94B | +386.4% | — | 12.3% | |
KEELKeel Infrastructure Corp. | Jun 2026 | $322.84M | +3165.9% | +47.8% | 22.8% |
WYFIWhiteFiber, Inc. Ordinary Shares | Mar 2026 | $1.38M | +111.5% | — | 21.5% |
| Mar 2026 | -$1.17M | -2484.8% | — | 3.2% | |
SHAZSharonAI Holdings, Inc. Class A Common Stock | Jun 2026 | -$849.99M | -112689.1% | — | 36.6% |
QMLSQumulusAI, Inc. Common Stock | — | — | — | — | — |
CHRNEkso Bionics Holdings, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SHAZ) | $1.13B | +322.6% | +165.0% | 22.2% | |
Competitors are the stored peer set for SHAZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 4.42M | 71.07M |
| Short-term Investments | 0 | 0 |
| Net Receivables | 984.55K | 15.92M |
| Inventory | 0 | 0 |
| Other Current Assets | 770.86K | 1.42M |
| Total Current Assets | 6.21M | 88.42M |
| Property, Plant & Equipment (Net) | 5.51M | 22.35M |
| Goodwill | 18.04M | 18.04M |
| Intangible Assets | 2.38M | 0 |
| Long-term Investments | 0 | 0 |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 0 | 4.33M |
| Total Non-current Assets | 25.94M | 44.72M |
| Total Assets | 32.15M | 133.14M |
| Account Payables | 404.85K | 3.43M |
| Short-term Debt | 5.44K | 131.27M |
| Tax Payables | 40.71K | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 50.16K | 3.59M |
| Total Current Liabilities | 1.15M | 139.37M |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 327.54K | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 |
| Total Non-current Liabilities | 1.09M | 3.92M |
| Total Liabilities | 2.24M | 143.29M |
| Common Stock | 107 | 1.2K |
| Retained Earnings | (3.91M) | (43.53M) |
| Accumulated OCI | 423.86K | (372.99K) |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 86.1K | (108.89K) |
| Total Equity | 29.91M | (10.15M) |
| Total Debt | 952.14K | 136.26M |
| Net Debt | (3.47M) | 65.19M |
SharonAI Holdings, Inc. Class A Common Stock
NASDAQ:SHAZ
Intrinsic Alpha fair value
Locked
Current Price
$21.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.